Work

P1.14-27 Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.1178

Authors: C. Baik, T. Patil, K. Kirtane, R. Santana-Davila, T. Rich, C. Espenschied, C. Weipert, S. Mach, K. Reckamp, R. Doebele

Institutions: Seattle Cancer Care Alliance, University of Washington, University of Colorado Denver, Guardant (United States), City Of Hope National Medical Center, City of Hope

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2982029042

FWCI:

Cites:

Cited by:

Related to: 10